SCHEMBL1664640

SCHEMBL1664640

Cn1cc(C(=O)Nc2ccc(Nc3ccc(Nc4ccc(N5CCC(O)CC5)cc4)cc3)c(Cl)c2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 2/20 0.43
DHX9 Q08211 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 1/20 0.41
KDM1A O60341 2/20 0.40
RCOR1 Q9UKL0 2/20 0.40
LCK P06239 2/20 0.40
MAPK14 Q16539 2/20 0.40
CSF1R P07333 1/20 0.40
WDR5 P61964 1/20 0.40
USP2 O75604 1/20 0.40
ABL1 P00519 1/20 0.39
WEE1 P30291 1/20 0.39
EGFR P00533 1/20 0.39
F10 P00742 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664641 0.96 LMNA (0.45) ALDH1A1LMNAMAPTDHX9NPC1
SCHEMBL1666960 0.89 ALDH1A1 (0.46) ALDH1A1LMNAMAPTDHX9NPC1
SCHEMBL1664186 0.86 RAB9A (0.50) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL1664809 0.86 EGFR (0.42) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL1666963 0.85 BRD4 (0.45) ALDH1A1LMNAMAPTDHX9NPC1
SCHEMBL1667332 0.85 MAPT (0.48) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL1664289 0.84 NPC1 (0.47) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL6126020 0.84 RAB9A (0.47) ALDH1A1MAPTNPC1RAB9AGAA
SCHEMBL6126044 0.84 RAB9A (0.47) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL21254900 0.84 MAPT (0.45) ALDH1A1LMNAMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed